Mr Chairman, IFPMA welcomes and supports the ongoing work and interim findings of the Review Committee on the Functioning of the IHR during the COVID-19 Response. Many critical issues have arisen through the Committee’s review process and it would be impossible for us to address all of these in the short amount of time we...
Read moreWe share the deep sense of responsibility that together we have to end this pandemic and are proud to be a founding member of the ACT A. We are keenly aware that science and innovation are only part of the equation. As part of our responsibility towards society, we must also ensure equitable global access...
Read moreIFPMA, PhRMA, EFPIA, Vaccines Europe, BIO, ICBA Statement With the first COVID-19 vaccines authorized by regulatory authorities and administered to the public, the biopharmaceutical industry, including leading vaccine makers, recognize that a critical new phase of the COVID-19 pandemic has begun. Collaboration among the global community has resulted in safe and efficacious vaccines being authorized...
Read moreThe Africa Young Innovators for Health Award is IFPMA and Speak Up Africa’s flagship programme to provide young entrepreneurs in the healthcare sector an opportunity to develop their business ideas and advance promising solutions to support, equip, protect, and train healthcare workers. Applications open from 11 January and close on 31 March 2021. The Award...
Read moreThis oped was originally published on Media Planet Vaccine Awareness Campaign on 22 December 2020 Vaccines are one of the most cost effective interventions we have to safeguard public health and yet during this pandemic we have seen a decrease in public confidence. The latest World Economic Forum/Ipsos survey found that the number of people...
Read moreLast week, IFPMA hosted the fifth and last CEO COVID-19 media briefing of 2020 with CEOs and top executives from Eli Lilly and Company, Johnson & Johnson, Pfizer and Roche. I joined the CEOs as they shared their take on progress achieved in 2020 and insights into 2021 and beyond. With this blog, I wanted...
Read moreIFPMA-IAPO Webinar: The African Medicines Agency: An important step towards increasing timely availability and access to medicinal products for patients in Africa. On December 8, 2020 the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) and the International Alliance of Patient Organisations (IAPO) organised a webinar that brought together regulators, patients and industry representatives as...
Read moreIn this video, Thomas Cueni, DG of IFPMA, speaks at Alzheimer’s Disease International 34th Conference Symposium: Supporting Early Career Researchers in Alzheimer’s and Dementia as part of the bursaries awards programme IFPMA supports to encourage new researchers to join the field of dementia research.
Read more